| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.34 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |